ENGENE THERAPEUTICS INC
ENGN · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $1.70
- Today’s Low
- $1.65
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.73
- Previous Close
- $1.70
- Volume
- 462.71K
- Market Cap
- $113.92M
- P/E Ratio
- --
- EPS
- $-2.07
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 4868 RUE LEVY, MONTREAL, QC, CANADA, H4R 2P1
- Country
- CA
- Listing Date
- 2021-12-10
- Fiscal Year End
- October
- Shares Outstanding
- 66.99M
- CIK
- 0001980845
- Website
- engene.com
enGene Holdings Inc., through its subsidiary enGene, Inc., is a clinical-stage biotechnology company that develops genetic medicines through the delivery of therapeutics to mucosal tissues and other organs. The company is headquartered in Saint-Laurent, Canada.
Financial Metrics
Revenue
2026-07-31
$0
2026-04-30
$0
2026-01-31
$0
2025-10-31
$0
Operating Expenses
2026-07-31
$34.01M
2026-04-30
$31.96M
2026-01-31
$30.99M
2025-10-31
$39.48M
Net Income
2026-07-31
$32.5M
2026-04-30
$30.22M
2026-01-31
-$29.75M
2025-10-31
-$37.88M
Net Profit Margin
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
--
Earnings Per Share
2026-07-31
$0.47
2026-04-30
$-0.43
2026-01-31
$-0.44
2025-10-31
$-0.73
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-07-31
-$33.83M
2026-04-30
-$31.78M
2026-01-31
-$28.83M
2025-10-31
-$37.45M
Effective Tax Rate
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
1.29%
| Item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $34.01M | $31.96M | $30.99M | $39.48M |
| Net Income | $32.5M | $30.22M | -$29.75M | -$37.88M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $0.47 | $-0.43 | $-0.44 | $-0.73 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$33.83M | -$31.78M | -$28.83M | -$37.45M |
| Effective Tax Rate | -- | -- | -- | 1.29% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.